Pharmadrug, Inc. engages in the research, development, and commercialization of controlled substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs. The Company operates through three distinct divisions. These divisions are Pharmadrug Production GmBH (“Pharmadrug Production”), Interrobang Ltd. (“Interrobang” or “Super Smart”) and Sairiyo Therapeutics Inc. (“Sairiyo”). It also holds minority interests on THC, CBD, Psilocybin, Cepharanthine (PD-001), and N, N-Dimethyltryptamine (“DMT”). The company was founded on September 6, 2011 and is headquartered in Toronto, Canada.